News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immucell Corp
(NQ:
ICCC
)
4.290
UNCHANGED
Streaming Delayed Price
Updated: 2:45 PM EDT, Jul 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
4.290
Bid (Size)
4.180 (1)
Ask (Size)
4.740 (1)
Prev. Close
4.290
Today's Range
4.290 - 4.290
52wk Range
4.050 - 5.870
Shares Outstanding
7,741,864
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday
Today 3:25 EDT
Via
Benzinga
ICCC Stock Earnings: ImmuCell Reported Results for Q1 2024
May 14, 2024
ImmuCell just reported results for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
-14.20%
-14.20%
1 Month
+0.12%
+0.12%
3 Month
-17.82%
-17.82%
6 Month
-14.71%
-14.71%
1 Year
-13.33%
-13.33%
More News
Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 12, 2023
Via
Benzinga
Earnings Scheduled For February 22, 2022
February 22, 2022
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
AngioDynamics, Disney And 3 Stocks To Watch Heading Into Wednesday
July 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 14, 2022
Via
Benzinga
Earnings Scheduled For November 21, 2022
November 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 05, 2022
Via
Benzinga
60 Biggest Movers From Yesterday
April 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 15, 2021
Via
Benzinga
Earnings Scheduled For November 15, 2021
November 15, 2021
Via
Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Via
Benzinga
Exposures
Product Safety
Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings
August 24, 2021
Via
Benzinga
Topics
Stocks
Exposures
US Equities
60 Biggest Movers From Yesterday
August 25, 2021
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 24, 2021
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
August 24, 2021
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
38 Stocks Moving In Tuesday's Mid-Day Session
August 24, 2021
Via
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
July 07, 2021
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
May 13, 2021
Via
Benzinga
Exposures
COVID-19
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Via
Benzinga
Exposures
COVID-19
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close